# FDA Inspection 822366 - Saint Joseph Hospital - March 15, 2013

Source: https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/4ef90aa3-8956-48cd-a1c7-fd461bc15dde
Source feed: FDA_Inspections

> FDA Inspection 822366 for Saint Joseph Hospital on March 15, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822366
- Company Name: Saint Joseph Hospital
- Inspection Date: 2013-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1070942 - 2018-10-17](https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/92a38d01-2007-4ceb-81ba-b8957a5c8ac3)
- [FDA Inspection 991905 - 2016-11-14](https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/1be8948b-e2d4-4c5e-9d8c-71666f6a9a45)
- [FDA Inspection 925936 - 2015-02-26](https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/d1013eb5-3c8c-4c2c-b279-161acf5b28bf)
- [FDA Inspection 727493 - 2011-06-08](https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/852023ef-f701-410f-8ded-ed40d3b93250)
- [FDA Inspection 727493 - 2011-06-08](https://www.keypedia.com/records/fda_inspections/saint-joseph-hospital/35ddea76-5c97-4c53-817c-a5f5fb4d0518)

Company: https://www.keypedia.com/companies/saint-joseph-hospital/7d2ef858-7ef6-4c14-bc1f-a1de51d93a88

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d